Osman Allen M, Madore Kevin P, Jaffe Paul I, Offidani Emanuela, Childress Ann C, Newcorn Jeffrey H, Schafer Robert J
Department of Research and Development, Lumos Labs, San Francisco, CA, USA.
Department of Psychology, Stanford University, Stanford, CA, USA.
Npj Ment Health Res. 2025 Aug 22;4(1):38. doi: 10.1038/s44184-025-00157-3.
We examined real-world evidence on whether Lumosity, a remote digital health technology designed to deliver cognitive training to healthy adults, can improve cognition and reduce inattention in adults who reported having received a prior (lifetime) diagnosis of ADHD. Over the course of Lumosity training, this cohort of commercial users was assessed repeatedly online with a neuropsychological test battery (NCPT) and a scale of attention and mood in real-world contexts (BAMS-7). More Lumosity training between successive assessments led to greater improvements on the NCPT composite measure and the attentional subscale of the BAMS-7. This positive dose-response relation was found for six of eight NCPT subtests and three of four BAMS-7 attentional items. Additional findings support the participants' clinical status and sensitivity of the assessments to ADHD symptoms. These findings provide evidence of cognitive and attentional benefits in a real-world cohort of adults reporting a lifetime diagnosis of ADHD from training with Lumosity under real-world conditions.
我们研究了关于Lumosity这一远程数字健康技术的真实世界证据，该技术旨在为健康成年人提供认知训练，能否改善那些报告曾有过（终生）注意力缺陷多动障碍（ADHD）诊断的成年人的认知能力并减少注意力不集中的情况。在Lumosity训练过程中，这一商业用户群体通过一套神经心理测试组合（NCPT）以及一个在现实环境中的注意力和情绪量表（BAMS - 7）进行了多次在线评估。在连续评估之间接受更多的Lumosity训练，会在NCPT综合测量以及BAMS - 7的注意力子量表上带来更大的改善。在八个NCPT子测试中的六个以及四个BAMS - 7注意力项目中的三个中发现了这种积极的剂量反应关系。其他研究结果支持了参与者的临床状况以及评估对ADHD症状的敏感性。这些发现为在现实世界条件下接受Lumosity训练的、报告有终生ADHD诊断的成年人真实世界群体中的认知和注意力益处提供了证据。
